Evofem Biosciences Inc (OTCMKTS:EVFM) Stock Falls Following a Key Update
On Monday Evofem Biosciences Inc (OTCMKTS:EVFM) was in the news after it announced that two more United States patents had been listed for its product Plexxi. The two indications had also been labelled in the United States Food and Drug Administration publication named Approved Drug Products with Therapeutic Equivalence Evaluations, which is more colloquially known as the Orange Book. Trading Data On Monday, EVFM stock slumped 11.43% to $0.0310 with…